Neoplasms of the Prostate Completed Phase 2 Trials for Abiraterone (DB05812)

Back to Neoplasms of the Prostate

Also known as: Neoplasms of Prostate / Neoplasms, Prostate / Prostate Neoplasm / Neoplasm, Prostate / Prostate Neoplasms / Neoplasm prostate / Neoplasms Prostate / Neoplasm of the prostate / Prostatic Neoplasms / Prostatic neoplasm NOS / Prostate neoplasia / Neoplasm of prostate (disorder) / Malignant tumor of prostate (disorder)

IndicationStatusPhase
DBCOND0080047 (Neoplasms of the Prostate)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01553188AMG 386 and Abiraterone for Advanced Prostate CancerTreatment
NCT01424930A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate CancerTreatment
NCT00544440An Observational Study of Continuous Oral Dosing of Abiraterone Acetate in Castration-Resistant Prostate Cancer Patients Evaluating Androgens and Steroid Metabolites in Bone Marrow PlasmaTreatment
NCT00474383An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based ChemotherapyTreatment